AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29745626 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentally-performed superficial neck flexor exercises
Number of subjects: 16
Study 29745626 — intervention group
Group type: EXPERIMENTAL
Intervention: Actively performed superficial neck flexor exercises
Number of subjects: 16
Study 29745626 — intervention group
Group type: EXPERIMENTAL
Intervention: Actively performed deep cervical flexor exercises
Number of subjects: 16
Study 29745626 — intervention group
Group type: COMPARATOR
Intervention: Actively performed deep cervical neck flexor exercises
Number of subjects: 16
Study 29745626 — intervention group
Group type: COMPARATOR
Intervention: Mentally performed deep cervical neck flexor exercises
Number of subjects: 16
Study 29484149 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 30
Study 26201750 — intervention group
Group type: EXPERIMENTAL
Intervention: Booklet only (Group A)
Number of subjects: 105
Study 26201750 — intervention group
Group type: EXPERIMENTAL
Intervention: Booklet with answers to clarification questions (Group B)
Number of subjects: 105
Study 26201750 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Group C)
Number of subjects: 105
Study 23744045 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for insomnia (CBT-I)
Number of subjects: 64
Study 23744045 — intervention group
Group type: COMPARATOR
Intervention: Sleep hygiene (SH) education program
Number of subjects: 64
Study 22998978 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutraceutical pill containing berberine (BBR)
Number of subjects: 258
Study 22998978 — intervention group
Group type: COMPARATOR
Intervention: Ezetimibe (EZE)
Number of subjects: 258
Study 22998978 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with BBR and EZE
Number of subjects: 258
Study 22998978 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of BBR in HeFH patients
Number of subjects: 258
Study 19194996 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive writing intervention (20 min writing for four consecutive days)
Number of subjects: 93
Study 19194996 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal care)
Number of subjects: 93
Study 18624109 — intervention group
Group type: EXPERIMENTAL
Intervention: Optoelectronic method (Truscreen)
Number of subjects: 147
Study 16005929 — intervention group
Group type: EXPERIMENTAL
Intervention: Motion coherence task
Number of subjects: 0
Study 16005929 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological motion task
Number of subjects: 0
Study 16005929 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-D form-from-motion task
Number of subjects: 0
Study 16005929 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 0
Study 12412864 — intervention group
Group type: COMPARATOR
Intervention: Oxygen-driven nebulizer (ODN)
Number of subjects: 196
Study 12412864 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-made non-valved spacer (NVS)
Number of subjects: 196
Study 10954008 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone (with the addition of atenolol or reserpine if needed)
Number of subjects: 4327
Study 10954008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4327
Study 9411420 — intervention group
Group type: EXPERIMENTAL
Intervention: Endogenous TNF alpha serum concentration monitoring
Number of subjects: 27
Study 9411420 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy persons)
Number of subjects: 27
Study 1489769 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotoner compression gloves
Number of subjects: 39
Study 1489769 — intervention group
Group type: EXPERIMENTAL
Intervention: Futuro compression gloves
Number of subjects: 39
Study 1489769 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 39
Study 2951178 — intervention group
Group type: EXPERIMENTAL
Intervention: porcine soluble and isophane, premixed porcine soluble/isophane, porcine soluble and lente, bovine ultralente with three porcine soluble injections before meals (all taken twice daily, and once daily for bovine ultralente)
Number of subjects: 12
Study 2951178 — intervention group
Group type: EXPERIMENTAL
Intervention: premixed insulins
Number of subjects: 12
Study 2951178 — intervention group
Group type: COMPARATOR
Intervention: various insulin regimens
Number of subjects: 12
Study 31810744 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 418
Study 31810744 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludrocortisone
Number of subjects: 418
Study 31810744 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 418
Study 30760277 — intervention group
Group type: EXPERIMENTAL
Intervention: alteplase-dose arm of the ENCHANTED trial (HSRCs)
Number of subjects: 774
Study 28376980 — intervention group
Group type: EXPERIMENTAL
Intervention: Vignette with white child
Number of subjects: 342
Study 28376980 — intervention group
Group type: COMPARATOR
Intervention: Vignette with black child
Number of subjects: 342
Study 25595117 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 200 mg tid
Number of subjects: 42
Study 25595117 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 22251431 — intervention group
Group type: EXPERIMENTAL
Intervention: In-group authority administering non-instrumental voice
Number of subjects: 0
Study 22251431 — intervention group
Group type: COMPARATOR
Intervention: Out-group authority administering non-instrumental voice
Number of subjects: 0
Study 21736814 — intervention group
Group type: EXPERIMENTAL
Intervention: Polydextrose (PDX) 21 g/d
Number of subjects: 21
Study 21736814 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble maize fibre (SCF) 21 g/d
Number of subjects: 21
Study 21736814 — intervention group
Group type: COMPARATOR
Intervention: No fibre control (NFC)
Number of subjects: 21
Study 19794266 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 500 mg b.i.d, amoxicillin 1g b.i.d, omeprazole 20 mg b.i.d, bismuth 240 mg b.i.d (MAO-B group)
Number of subjects: 60
Study 19794266 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg once daily for 1 week, amoxicillin 1g b.i.d, omeprazole 20 mg b.i.d, bismuth 240 mg b.i.d for 2 weeks (AAO-B group)
Number of subjects: 60
Study 16333556 — intervention group
Group type: EXPERIMENTAL
Intervention: Alvimopan 6 mg
Number of subjects: 615
Study 16333556 — intervention group
Group type: EXPERIMENTAL
Intervention: Alvimopan 12 mg
Number of subjects: 615
Study 16333556 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 615
Study 14738417 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulthiame (STM)
Number of subjects: 37
Study 14738417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 11050374 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.8% hypertonic saline infusion
Number of subjects: 36
Study 11050374 — intervention group
Group type: COMPARATOR
Intervention: 0.9% isotonic saline infusion (control)
Number of subjects: 36
Study 11050374 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.8% saline infusion with feedback from the right masseter sEMG
Number of subjects: 36
Study 11050374 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.8% saline infusion with both sEMG and imEMG recorded
Number of subjects: 36
Study 9152116 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiagabine 16 mg 2 times per day
Number of subjects: 351
Study 9152116 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiagabine 8 mg 4 times daily
Number of subjects: 351
Study 9152116 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351
Study 8423882 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum-A toxin (BTX-A) injections
Number of subjects: 20
Study 8423882 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 20
Study 3622203 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous insulin infusion
Number of subjects: 5
Study 3622203 — intervention group
Group type: COMPARATOR
Intervention: Intravenous insulin infusion
Number of subjects: 5
Study 29338111 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (12 weeks, twice-weekly)
Number of subjects: 53
Study 29338111 — intervention group
Group type: COMPARATOR
Intervention: Usual care without scheduled physical exercise
Number of subjects: 53
Study 27650928 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant formula enriched by functional ingredients (n = 24)
Number of subjects: 60
Study 27650928 — intervention group
Group type: COMPARATOR
Intervention: Standard formula (n = 25)
Number of subjects: 60
Study 27650928 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusively breast-fed (n = 11)
Number of subjects: 60
Study 26584856 — intervention group
Group type: EXPERIMENTAL
Intervention: Sit-stand workstation
Number of subjects: 47
Study 23680075 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended VBRT (36 weeks)
Number of subjects: 130
Study 23680075 — intervention group
Group type: COMPARATOR
Intervention: Standard VBRT (12 weeks)
Number of subjects: 130
Study 23680075 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 130
Study 21210170 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentian violet (GV) 0.00165%
Number of subjects: 15
Study 21210170 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentian violet (GV) 0.1%
Number of subjects: 15
Study 21210170 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentian violet (GV) 0.0085%
Number of subjects: 15
Study 18086028 — intervention group
Group type: EXPERIMENTAL
Intervention: PQI adhesive system
Number of subjects: 60
Study 18086028 — intervention group
Group type: EXPERIMENTAL
Intervention: OptiBond Solo Plus adhesive system
Number of subjects: 60
Study 16941631 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (100 mg)
Number of subjects: 0
Study 16941631 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpheniramine (4 mg)
Number of subjects: 0
Study 16941631 — intervention group
Group type: COMPARATOR
Intervention: Control (no vasomodulator)
Number of subjects: 0
Study 12865903 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic seizure therapy (MST)
Number of subjects: 10
Study 12865903 — intervention group
Group type: COMPARATOR
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 10
Study 10863253 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar posteroanterior mobilization
Number of subjects: 26
Study 10863253 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 26
Study 10423616 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac potassium (25 mg)
Number of subjects: 255
Study 10423616 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac potassium (50 mg)
Number of subjects: 255
Study 10423616 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac potassium (100 mg)
Number of subjects: 255
Study 10423616 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (650 mg)
Number of subjects: 255
Study 10423616 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study 7862904 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone (100-400 mg/day)
Number of subjects: 106
Study 7862904 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline (50-200 mg/day)
Number of subjects: 106
Study 2678877 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl TTS (transdermal drug delivery system, delivery rate of 75 micrograms/hour)
Number of subjects: 60
Study 2678877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 766800 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide continuously
Number of subjects: 99
Study 766800 — intervention group
Group type: COMPARATOR
Intervention: Combination of cyclophosphamide, methotrexate, 5-fluorouracil and vinblastine given intermittently
Number of subjects: 99
Study 31089777 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment with a newly introduced technique (annular closure device) during standard operation
Number of subjects: 0
Study 31089777 — intervention group
Group type: COMPARATOR
Intervention: Standard surgical treatment without the annular closure device
Number of subjects: 0
Study 31238908 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet-based training programme during and for 9 months after the MKP
Number of subjects: 0
Study 31238908 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 0
Study 28470676 — intervention group
Group type: EXPERIMENTAL
Intervention: NDI‐010976 (20 mg)
Number of subjects: 0
Study 28470676 — intervention group
Group type: EXPERIMENTAL
Intervention: NDI‐010976 (50 mg)
Number of subjects: 0
Study 28470676 — intervention group
Group type: EXPERIMENTAL
Intervention: NDI‐010976 (200 mg)
Number of subjects: 0
Study 28470676 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26385134 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold gel pack (3-5 °C)
Number of subjects: 35
Study 26385134 — intervention group
Group type: COMPARATOR
Intervention: Room-temperature gel pack (20 °C)
Number of subjects: 35
Study 25004184 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram as adjunctive therapy to risperidone and olanzapine
Number of subjects: 90
Study 25004184 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine as adjunctive therapy to risperidone and olanzapine
Number of subjects: 90
Study 25004184 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 22798534 — intervention group
Group type: EXPERIMENTAL
Intervention: IV dexamethasone 0.5 mg/kg
Number of subjects: 160
Study 22798534 — intervention group
Group type: COMPARATOR
Intervention: IV methylprednisolone 2.5 mg/kg
Number of subjects: 160
Study 19650710 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal 0.2 mL autologous plasmin enzyme (APE) injection
Number of subjects: 16
Study 19650710 — intervention group
Group type: COMPARATOR
Intervention: Control eye (no injection)
Number of subjects: 16
Study 17893531 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 12
Study 17893531 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotic membrane transplantation (AMT)
Number of subjects: 12
Study 17893531 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous limbal transplantation (ALT)
Number of subjects: 12
Study 17893531 — intervention group
Group type: EXPERIMENTAL
Intervention: ALT + AMT
Number of subjects: 12
Study 14754695 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly courses of betamethasone
Number of subjects: 161
Study 14754695 — intervention group
Group type: COMPARATOR
Intervention: Single course of betamethasone
Number of subjects: 161
Study 12139812 — intervention group
Group type: EXPERIMENTAL
Intervention: Limbal epithelial autograft transplantation (A group)
Number of subjects: 208
Study 12139812 — intervention group
Group type: COMPARATOR
Intervention: Simple pterygium excision (B group)
Number of subjects: 208
Study 10186934 — intervention group
Group type: EXPERIMENTAL
Intervention: Worksite intervention program focusing on social cognitive theory constructs, including self-regulation techniques and outcome-expectancy value.
Number of subjects: 0
Study 10186934 — intervention group
Group type: COMPARATOR
Intervention: Comparison group received a program of assessment, instruction, and access to facilities common in worksite fitness promotion programs.
Number of subjects: 0
Study 7561987 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-reported measures of ETS exposure
Number of subjects: 91
Study 2048574 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin therapy
Number of subjects: 118
Study 2048574 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study 6171080 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive policy (I)
Number of subjects: 150
Study 6171080 — intervention group
Group type: COMPARATOR
Intervention: Routine policy (R)
Number of subjects: 150
Study 31136656 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat load (150 g of fat)
Number of subjects: 10
Study 31136656 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat load with fructose (3 doses of 50 g)
Number of subjects: 10
Study 31136656 — intervention group
Group type: COMPARATOR
Intervention: High-fat load with glucose (3 doses of 50 g)
Number of subjects: 10
Study 31136656 — intervention group
Group type: COMPARATOR
Intervention: Fasting
Number of subjects: 10
Study 31136656 — intervention group
Group type: COMPARATOR
Intervention: Repeated doses of fructose (3 doses of 50 g)
Number of subjects: 10
Study 31136656 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose (3 doses of 50 g)
Number of subjects: 10
Study 28412240 — intervention group
Group type: EXPERIMENTAL
Intervention: High mental effort (HME)
Number of subjects: 18
Study 28412240 — intervention group
Group type: EXPERIMENTAL
Intervention: Low mental effort (LME)
Number of subjects: 18
Study 28412240 — intervention group
Group type: COMPARATOR
Intervention: No-training control (CTRL)
Number of subjects: 18
Study 25976238 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Morphine Sulfate
Number of subjects: 60
Study 25976238 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading dose of Phenobarbital followed by tapering dose
Number of subjects: 60
Study 23043876 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity two-legged exercise
Number of subjects: 8
Study 22103649 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth-implant-supported fixed prostheses (TISPs)
Number of subjects: 13
Study 22103649 — intervention group
Group type: COMPARATOR
Intervention: Implant-supported prostheses (ISPs)
Number of subjects: 13
Study 22103649 — intervention group
Group type: EXPERIMENTAL
Intervention: Both TISPs and ISPs
Number of subjects: 13
Study 19563522 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease-specific nutrition treatment (standard diet plus a 400-mL oral supplement or specific enteral formula enriched with protein, 20% of total calories, arginine, zinc, and vitamin C)
Number of subjects: 28
Study 19563522 — intervention group
Group type: COMPARATOR
Intervention: Standard nutrition (hospital diet or standard enteral formula; 16% calories from protein)
Number of subjects: 28
Study 16389668 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyzine 25 mg (HYD) with alcohol (ALC)
Number of subjects: 18
Study 16389668 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg (CET) with alcohol (ALC)
Number of subjects: 18
Study 16389668 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine 20 mg (RUP) with alcohol (ALC)
Number of subjects: 18
Study 16389668 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine 10 mg (RUP) with alcohol (ALC)
Number of subjects: 18
Study 16389668 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 18
Study 16389668 — intervention group
Group type: COMPARATOR
Intervention: Alcohol alone (ALC)
Number of subjects: 18
Study 16296259 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional toothcleaning (PTC), oral hygiene instruction, and motivation (test group)
Number of subjects: 40
Study 16296259 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 40
Study 10989320 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscarinic receptor stimulation by metacholine (Mch)
Number of subjects: 6
Study 10989320 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroprusside (SNP)
Number of subjects: 6
Study 10989320 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 6
Study 10989320 — intervention group
Group type: EXPERIMENTAL
Intervention: 17-beta estradiol (E) infusion (20 ng/min)
Number of subjects: 6
Study 1889973 — intervention group
Group type: EXPERIMENTAL
Intervention: PMMA membrane dialyzer
Number of subjects: 200
Study 1889973 — intervention group
Group type: COMPARATOR
Intervention: Cuprophane membrane dialyzer
Number of subjects: 200
Study 6361737 — intervention group
Group type: EXPERIMENTAL
Intervention: Y connector system filled with sodium hypochlorite
Number of subjects: 62
Study 6361737 — intervention group
Group type: COMPARATOR
Intervention: Standard Oreopoulos CAPD system
Number of subjects: 62
Study 30794565 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait speed
Number of subjects: 20
Study 30794565 — intervention group
Group type: EXPERIMENTAL
Intervention: Stride length
Number of subjects: 20
Study 30794565 — intervention group
Group type: EXPERIMENTAL
Intervention: Trailing limb angle
Number of subjects: 20
Study 29803427 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical extraction system
Number of subjects: 240
Study 29803427 — intervention group
Group type: COMPARATOR
Intervention: Conventional tooth extraction techniques
Number of subjects: 240
Study 27372219 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch treatment (21mg) with counseling for 8 weeks
Number of subjects: 180
Study 27372219 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in craving
Number of subjects: 180
Study 24343281 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab use
Number of subjects: 499
Study 24343281 — intervention group
Group type: EXPERIMENTAL
Intervention: PCDAI and SES
Number of subjects: 499
Study 24343281 — intervention group
Group type: EXPERIMENTAL
Intervention: PCDAI
Number of subjects: 499
Study 24343281 — intervention group
Group type: EXPERIMENTAL
Intervention: SES
Number of subjects: 499
Study 22489806 — intervention group
Group type: EXPERIMENTAL
Intervention: Real plants
Number of subjects: 457
Study 22489806 — intervention group
Group type: EXPERIMENTAL
Intervention: Posters of plants
Number of subjects: 457
Study 22489806 — intervention group
Group type: COMPARATOR
Intervention: No nature (control)
Number of subjects: 457
Study 19819203 — intervention group
Group type: EXPERIMENTAL
Intervention: Cola-flavoured ORS
Number of subjects: 116
Study 19819203 — intervention group
Group type: EXPERIMENTAL
Intervention: Strawberry-flavoured ORS
Number of subjects: 116
Study 19819203 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral solution
Number of subjects: 116
Study 19819203 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit-flavoured ORS
Number of subjects: 116
Study 19819203 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall preference
Number of subjects: 116
Study 17713794 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-cost rehabilitation program with a behavioural element
Number of subjects: 90
Study 17713794 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual exercise therapy
Number of subjects: 90